Skip Navigation
Skip to contents

Intest Res : Intestinal Research

Search
Advanced Search
IMPACT FACTOR
mobile search button mobile menu button

Articles

Page Path
HOME > Intest Res > Volume 15(4); 2017 > Article
Original Article Local recurrence and subsequent endoscopic treatment after endoscopic piecemeal mucosal resection with or without precutting in the colorectum
Myeongsook Seo, Eun Mi Song, Gwang Un Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
Intestinal Research 2017;15(4):502-510.
DOI: https://doi.org/10.5217/ir.2017.15.4.502
Published online: October 23, 2017

Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Correspondence to Jeong-Sik Byeon, Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Tel: +82-2-3010-3905, Fax: +82-2-3010-5782, jsbyeon@amc.seoul.kr
• Received: December 28, 2016   • Revised: March 20, 2017   • Accepted: March 29, 2017

© Copyright 2017. Korean Association for the Study of Intestinal Diseases.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • 6,310 Views
  • 82 Download
  • 10 Web of Science
  • 10 Crossref
  • 11 Scopus
Full Article

Download PDF Download PDF

  • Background/Aims
    Precutting before endoscopic piecemeal mucosal resection (EPMR) may increase colorectal polyp resection effectiveness. We aimed to identify risk factors for recurrence after conventional EPMR (CEPMR) and precut EPMR (PEPMR) and investigated endoscopic treatment outcomes for recurrent cases.
  • Methods
    The medical records of patients with colorectal polyps treated by EPMR were analyzed. Patients without follow-up surveillance colonoscopies were excluded.
  • Results
    Among 359 lesions, the local recurrence rate on the first surveillance colonoscopy was 5.8% (18/312) and 6.4% (3/47) after CEPMR and PEPMR, respectively. Among lesions without recurrence at the first surveillance colonoscopy, the rates of late recurrence on subsequent surveillance colonoscopy were 3.9% (6/152) and 0% after CEPMR and PEPMR, respectively. Larger tumor size was the only independent risk factor for recurrence (odds ratio, 7.93; 95% confidence interval, 1.95–32.30; P<0.001). Endoscopic treatment was performed for all 27 recurrences. A combination of ≥2 endoscopic treatment modalities was used in 19 of 27 recurrences (70.4%). Surveillance colonoscopies were performed in 20 of 27 recurrences after endoscopic treatment. One (5.0%) had a re-recurrence and was treated by surgical resection because recurrence occurred at the appendiceal orifice. Nineteen of 20 lesions (95.0%) could be cured endoscopically, although 3 of the 19 showed second or third recurrences and were treated by repeat endoscopic resection.
  • Conclusions
    The local recurrence rates after CEPMR and PEPMR were similar. Larger tumor size was an independent risk factor for local recurrence after EPMR. Endoscopic treatment of recurrences resulted in high cure rates, although combination methods were necessary in many cases.
  • Keywords: Endoscopic mucosal resection; Colonic neoplasia; Piecemeal resection
The endoscopic mucosal resection (EMR) technique has been widely used for the resection of colorectal neoplasms. Endoscopic piecemeal mucosal resection (EPMR) is used in up to 50% of cases for resection of large lesions of >20 mm in diameter.1234 The local recurrence rate is higher with EPMR than with en bloc resection. The local recurrence rate after EPMR has been reported to be up to 50%, compared with a rate of 0% to 17.8% after en bloc resection.156 Endoscopic submucosal dissection is an effective procedure for en bloc resection of large colorectal neoplasms. However, endoscopic submucosal dissection has not been widely used because it is technically difficult to perform and carries a considerable risk of perforation.578910 Therefore, EMR with circumferential precutting (precut EMR) has been introduced as an alternative method for resecting large polyps.11 Several studies demonstrated that precut EMR had higher en bloc resection rates and lower recurrence rates than conventional EMR.812 However, precut EMR also had a piecemeal resection rate with a range of 34.0% to 54.9% in large lesions.812 Despite this high piecemeal rate with precut EMR, the recurrence rate after precut EPMR (PEPMR) has not been extensively investigated compared with conventional EPMR (CEPMR).
There have been few studies of the clinical outcome of endoscopic treatment for recurrent lesions after EPMR.11314 A recent Australian study of colonic EMR reported that 135 of 145 recurrent/residual adenomas (93.1%) were successfully treated endoscopically.1 However, this study did not describe the detailed methods, such as EMR, avulsion using hot biopsy forceps, and argon plasma coagulation (APC). Thus, further studies are necessary to evaluate the performance and outcome of salvage treatment for recurrent lesions after EPMR.
The aims of our study were to compare the outcomes of CEPMR and PEPMR and to identify risk factors for local recurrence after EPMR. In addition, we aimed to investigate the performance and outcome of endoscopic treatment for recurrent lesions.
1. Patients
We retrospectively analyzed data regarding 359 lesions in 344 patients who underwent EPMR and who had at least 1 surveillance colonoscopy or sigmoidoscopy after the initial EPMR for a colorectal polyp of ≥10 mm diameter at the Asan Medical Center between January 2005 and December 2014 (Fig. 1). We searched for EPMR cases by searching for the term “piecemeal” in the colonoscopy report found with a search of the computerized database at our institution. After initial selection of EPMR cases by this system, we reviewed all the colonoscopy images of these patients and finally enrolled the EPMR cases in this study. We excluded patients with a positive deep resection margin. All procedures were performed by 8 experienced endoscopists and 15 trainee endoscopists using CEPMR or PEPMR methods. All of the 8 experienced endoscopists had >10 years of experience in diagnostic and therapeutic colonoscopies. They performed 94.9% of the CEPMR cases and 95.7% of the PEPMR cases. Cases in which the patient had undergone EPMR for subepithelial lesions, such as neuroendocrine tumor, leiomyoma, and granular cell tumor were excluded; the patients who had familial adenomatous polyposis or UC were also excluded. All patients provided written informed consent to undergo endoscopic resection of colorectal polyps. This study was approved by the Institutional Review Board of the Asan Medical Center, Seoul, Korea (IRB number: 2015-0954) and waived for informed consent.
2. EPMR Procedures
A single-channel endoscope was used to perform EPMR procedures. We used a mixed solution of normal saline with epinephrine (1:10,000) for submucosal injection. A small amount of indigo carmine was added to the solution to improve the visibility of the submucosal layer and polyp edges. For CEPMR, after submucosal injection, part of the polyp was snared and resected by electrical current. Repeat snaring and resection was performed until most of the lesion had been resected. If a small residual lesion was left, avulsion was performed with the use of hot biopsy forceps. If a tiny invisible residual was suspected because of multiple resections, APC or snare tip coagulation was used for fulguration. For PEPMR, a circumferential incision was made 2 to 4 mm from the edge of the polyp by electrical cutting with the snare tip or dual knife (Olympus Co., Tokyo, Japan) after submucosal injection. A snare was placed at the cut groove, and part of the polyp was grasped by squeezing the snare. Resection was then performed with the use of the electrosurgical current. Repeat snaring and resection were performed in a similar manner to CEPMR. Avulsion, APC, and snare tip coagulation were added in the same manner as CEPMR if they were needed. Fig. 2 shows representative figures of the CEPMR and PEPMR cases. ICC200 and VIO300D (ERBE, Tubingen, Germany) were used as electrosurgical units.
3. Surveillance Colonoscopy
All patients were advised to have periodic follow-up surveillance colonoscopies or sigmoidoscopies to evaluate local recurrence at the EPMR sites. The first surveillance colonoscopy or sigmoidoscopy was recommended to be at 3 to 12 months after the initial EPMR. The length of time to the second surveillance was determined based on the findings of the first surveillance endoscopy. If the first surveillance showed no recurrence, the second surveillance was recommended to be performed after 1 to 3 years at the discretion of the endoscopist, according to the number, size, and pathology of the polyps resected at the initial colonoscopy with EPMR. If the first surveillance showed local recurrence, endoscopic retreatment was attempted, and the next surveillance endoscopy was recommended again in 3 to 12 months.
4. Baseline Characteristics and Outcome Measurements
We investigated the baseline characteristics of the polyps, such as location, size, morphology, and presence or absence of previous biopsy before EPMR. The morphological types of colorectal polyps were classified as the laterally spreading tumor-granular type, the laterally spreading tumor-nongranular type, and the sessile/protruded type. The sessile/protruded type was a 0–Is polyp in the Paris classification. One of the complications, intraprocedural bleeding, was defined as bleeding that developed during the endoscopic resection, interrupted the endoscopic resection procedure, and finally required endoscopic hemostasis with the use of hemostatic forceps, APC, and/or clipping. Delayed bleeding was defined as hematochezia and/or melena that developed after the completion of the colonoscopy procedures and required endoscopic hemostasis. Delayed bleeding was divided into early (≤48 hours after EPMR) and late (>48 hours after EPMR) bleeding. Perforation was identified based on the endoscopic evidence of a definite mural defect with the visualization of intraperitoneal organs or periserosal fat tissue.
Resected specimens were retrieved and reconstructed to be as close to the original shape of the polyp as possible. They were then fixed in 10% formalin and microscopically evaluated. Histological diagnoses were made according to the Vienna classification.15 Histological complete resection was defined as the absence of tumor cells at the lateral and deep resection margins of the reconstructed specimen. The definition of a superficial submucosal cancer was a cancer with a depth of submucosal cancer invasion <1,000 µm from the muscularis mucosa.
During surveillance endoscopy, routine biopsy was not performed if the EPMR site showed a completely clear scar without any abnormality. Biopsy was performed if a visible recurrent lesion was detected at the scar or any suspicious abnormality was observed, even if it was subtle. Recurrence was defined as a histologically confirmed colorectal neoplasm that was detected on the scar of the previous EPMR site. Late recurrence was defined as local recurrence discovered at the subsequent colonoscopy approximately 12 months after the first surveillance colonoscopy in which the local recurrence was absent. If a recurrent lesion was detected, endoscopic treatment was attempted. The principal endoscopic treatment method for recurrences was EMR, and supplementary methods, such as cold biopsy, hot biopsy, and APC, were applied if necessary to completely remove all the recurrent lesions.
5. Statistical Analysis
Continuous variables were expressed as means with SD or medians with interquartile range (IQR), as appropriate. Continuous parameters were analyzed by the Student t-test or the Mann-Whitney U-test. Categorical variables were compared by the chi-square test or Fisher exact test, as appropriate. A logistic regression model was used for multivariate analysis of risk factors for recurrence. P-values of <0.05 were considered to indicate statistical significance. All statistical analyses were performed with SPSS version 21.0 for Windows (IBM Corp., Armonk, NY, USA).
1. Baseline Characteristics
The baseline characteristics of the patients, polyps, and EPMR procedures are summarized in Table 1. Of 359 lesions in 344 patients, CEPMR was performed for 312 lesions (87%) and PEPMR was performed for 47 lesions (13%). The mean age of the patients was similar in the CEPMR and PEPMR groups. The morphological types of the lesions were not different in the 2 groups. However, the mean diameter of the tumors treated with PEPMR (28.5±15.4 mm) was larger than that of those treated with CEPMR (23.7±12.0 mm) (P=0.009).
2. Short-Term Outcomes after EPMR
The details of the procedure-related variables and histological outcomes are described in Table 2. The average number of resected pieces per case was similar in the CEPMR and PEPMR groups. The distribution of histological diagnoses was also similar in both groups. Adenoma was the most common pathology in both groups. The histological complete resection rate was higher in the CEPMR group (40.1%) than in the PEPMR group (31.9%) (P=0.003). Intraprocedural bleeding was more frequent in the PEPMR group than in the CEPMR group (31.9% vs. 12.5%, P=0.001).
3. Long-Term Outcomes after EPMR
The median time to the first surveillance colonoscopy was 7.9 months (IQR, 4.9–12.8 months), and the overall duration of follow-up was 20.0 months (IQR, 12.3–38.3 months). The overall recurrence rate during the study period was 7.5% (27/359). The recurrence rates were not significantly different in the CEPMR and PEPMR groups (7.7% vs. 6.4%, P>0.751) (Table 2). Local recurrence at the first surveillance endoscopy was observed in 18 of 312 lesions (5.8%) after CEPMR and in 3 of 47 lesions (6.4%) after PEPMR. Among lesions that did not have a recurrence at the first surveillance colonoscopy, the rate of late recurrence on subsequent surveillance colonoscopy was 3.9% (6/152) after CEPMR and 0% after PEPMR (Fig. 1). The median time to late recurrence after CEPMR was 16.0 months (IQR, 14.5–20.6 months). Recurrence rates increased as lesion size increased in both groups (Table 3).
In the univariate analysis, local recurrence was associated with tumor size, tumor morphology, number of resected pieces, and perforation. However, multivariate analysis revealed that larger tumor size was the only independent risk factor for recurrence (Table 4).
4. Performance of Endoscopic Treatment for Recurrent Lesions
Among 27 recurrent tumors, 2 cases recurred as sessile serrated adenomas and the remaining 25 cases recurred as adenomas/villous adenomas. No case recurred as cancer after removal of an adenoma. Salvage endoscopic treatment was performed for all 21 recurrent lesions at the first surveillance endoscopy. Single endoscopic treatment methods, such as cold forceps polypectomy or EMR, were used in 3 recurrent lesions, and combination methods (EMR plus APC, EMR plus hot biopsy, EMR plus hot biopsy plus APC, cold forceps polypectomy plus APC, or hot biopsy plus APC) were used in 18 recurrent lesions. Of these 21 recurrent lesions, 15 underwent surveillance endoscopies after endoscopic treatment. Of the latter 15 lesions, 3 (20.0%) had a second recurrence at the subsequent surveillance endoscopy; 1 patient underwent surgical appendectomy because the recurrence was at the appendiceal orifice, and the other 2 underwent repeat endoscopic treatment.
Salvage endoscopic treatment was performed for all 6 late recurrences at the second or third surveillance endoscopy in cases without recurrence at the first surveillance endoscopy. A single endoscopic treatment modality was used in 5 late recurrences and a combination method in 1 late recurrence. Of these 6 patients with late recurrence, 5 underwent subsequent surveillance endoscopy and showed no further recurrence.
In summary, 21 lesions (5.8%) showed local recurrence at the first surveillance endoscopy, and 6 lesions (3.9%) showed late recurrence at subsequent surveillances, although they had not had recurrence at the first surveillance. All 27 recurrences were treated endoscopically. A single modality was used in 8 recurrences (29.6%), and combination methods were used in 19 recurrences (70.4%) (Table 5). Twenty of 27 recurrences were followed up by subsequent endoscopy. Of these, 1 (5.0%) was treated by surgical appendectomy because of re-recurrence at the appendiceal orifice, and the other 19 (95.0%) were cured by endoscopic treatment, although 3 of the 19 showed second or third recurrences, which were treated by repeat endoscopic treatment. A flowchart detailing recurrence and subsequent endoscopic treatment is presented in Fig. 1.
In our meticulous review, we found that the rates of recurrence after CEPMR and PEPMR were not different. Large tumor size increased the risk of local recurrence after EPMR. Recurrent lesions could be managed by endoscopic treatment in most cases, which was usually combination therapy rather than a single method.
Previous studies reported that the local recurrence rate after EPMR was 6.9% to 23.5%.1316171819 A recent meta-analysis showed that the recurrence rate after EPMR was 11% to 54% for lesions ≥20 mm and the pooled estimate of recurrence risk was 22%, compared with only 3% after en bloc EMR.18 In our study, the overall local recurrence rates of CEPMR and PEPMR were 7.7% (24/312) and 6.4% (3/47) for colorectal polyps ≥10 mm (P>0.999). For polyps ≥20 mm, the recurrence rates were 10.6% (21/199) after CEPMR and 7.9% (3/38) after PEPMR (P=0.775). The recurrence rates in our study are within the ranges of earlier reports. The rate of late recurrence at the second or third surveillance endoscopy without recurrence at the first surveillance was 3.9% (6/152) after CEPMR, whereas there was no late recurrence after PEPMR. The late recurrence rate after CEPMR in our study is also consistent with a previous study that showed a late recurrence rate of approximately 4%.12 An interesting point of our study is that there was no difference in recurrence rates after CEPMR and PEPMR. Although precut incision with a safety margin can guarantee a clear lateral resection margin and theoretically provide a higher complete resection rate than conventional EMR,1112 it cannot eliminate the risk of tumor remaining between the pieces after EPMR. The tumor remaining between the pieces may grow and lead to recurrent tumors detected at follow-up surveillance endoscopy. We suggest this may be one reason that the recurrence rates were not different between CEPMR and PEPMR. Another point worthy of note in our study is the lower histological complete resection rate (31.9%) after PEPMR compared with 40.1% after CEPMR. We expected a higher histological complete resection rate after PEPMR because of the precut incision with safety margin. However, the result was contrary to our hypothesis. We believe that the lower complete resection rate after PEPMR may be related to thermal injury of the resection margin during circumferential incision.11 Although the resection itself was complete, without involvement of the resection margins by tumor tissue, thermal injury may have made precise histological evaluation difficult and resulted in positive or indeterminate resection margins.
Larger tumor size (≥40 mm) was the only independent risk factor for local recurrence after EPMR, regardless of piecemeal resection methods. As the size of the polyp increases, the number of pieces may increase during EPMR. If the number of pieces increases, the risk of remnant tumor between pieces may increase, thereby increasing the risk of recurrence. Therefore, we suggest that adequate strategies to decrease the risk of recurrence should be considered after EPMR of large polyps, especially those of diameter ≥40 mm. Utilizing APC may be 1 option to decrease the risk of recurrence,2021 and routine application of APC may be considered after EPMR of polyps with ≥40 mm diameter. Avulsion of visible residual tumor with hot biopsy forceps may be another method to minimize the risk of recurrence after EPMR.22 In addition, we suggest that more careful endoscopic surveillance should be considered after EPMR of polyps with ≥40 mm diameter because of the higher risk of recurrence.
Although local recurrence rates were not low, endoscopic treatment ultimately provided a high cure rate of 95% (19/20), despite repeat recurrences in some cases. Only 1 case (5%) underwent surgical management because the recurrent lesion involved the appendiceal orifice and extended into the appendiceal lumen. Regarding the endoscopic treatment methods, 70.4% of all recurrences (19/27) were treated not by single endoscopic therapy but by combination therapy (EMR plus APC, EMR plus hot biopsy, EMR plus hot biopsy plus APC, cold forceps polypectomy plus APC, or hot biopsy plus APC). Because recurrent lesions after endoscopic resection, especially wide resection, such as EPMR of large polyps, may develop in the background of the scar tissue, the non-lifting sign may be present and endoscopic resection may be much more difficult than endoscopic resection of polyps with no previous attempt at resection.2123 Hence, a single endoscopic treatment method may not be sufficient for complete removal of the recurrent lesions on the scar.24 This may be a reason why combination therapy was used in most cases of recurrence. Even though a combination of methods was needed, endoscopic management was very effective for treatment of recurrent lesions after EPMR. Future studies should investigate the most useful endoscopic methods for treatment of recurrent lesions on the scar.
Complication rates after CEPMR and PEPMR were not different except for a higher rate of intraprocedural bleeding after PEPMR. Circumferential precutting by the snare tip or endo-knives may have been the reason for higher intraprocedural bleeding during PEPMR. Despite the absence of differences in delayed bleeding and other complications, considering the more frequent intraprocedural bleeding during PEPMR and the absence of difference in local recurrence rates between CEPMR and PEPMR, we suggest that PEPMR may not be recommended routinely for resection of large polyps and CEPMR should be the first choice. However, because of the theoretical advantage of minimal risk of slipping of the tumor out of the snare during closure of the snare, PEPMR may be indicated for resection of very flat tumors that are liable to slip out of the snare. Our study was a retrospective one, and we could not evaluate and analyze the usefulness of PEPMR from this viewpoint. Future studies are needed to clearly define the possible indications for PEPMR.
Our study had several limitations. First, because it was a retrospective study based on experience in a single center, selection bias related to the choice of PEPMR might have influenced the clinical outcomes and recurrence rates. Additionally, we searched for EPMR cases from the database of our institution by the computerized searching system using the term “piecemeal.” Because the searching system was not perfect, many EPMR cases may have been missed, which is another cause of selection bias of this study. The second limitation is the absence of a detailed analysis on the probable difference in the endoscopic skill between experienced and trainee endoscopists. Therefore, we do not know whether the expertise in endoscopic technique may have influenced the outcomes after EPMR. Third, because only half of the enrolled patients underwent a second surveillance, the local recurrence rates might be underestimated. Finally, the median follow-up period was <2 years. Despite these weaknesses, we believe that the present study is meaningful because, to the best of our knowledge, our investigation is the first study comparing clinical outcomes between CEPMR and PEPMR.
In conclusion, local recurrence rates were not different in CEPMR and PEPMR. Large tumor size was the only independent risk factor for local recurrence after EPMR. Endoscopic treatment for recurrent lesions resulted in a high cure rate, although the majority of recurrences required a combination of 2 or more endoscopic treatment methods.

Financial support: None.

Conflict of interest: None.

  • 1. Moss A, Williams SJ, Hourigan LF, et al. Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study. Gut 2015;64:57–65.PMID: 24986245.ArticlePubMed
  • 2. Khashab M, Eid E, Rusche M, Rex DK. Incidence and predictors of “late” recurrences after endoscopic piecemeal resection of large sessile adenomas. Gastrointest Endosc 2009;70:344–349.PMID: 19249767.ArticlePubMed
  • 3. Oka S, Tanaka S, Saito Y, et al. Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am J Gastroenterol 2015;110:697–707.PMID: 25848926.ArticlePubMedPDF
  • 4. Tanaka S, Haruma K, Oka S, et al. Clinicopathologic features and endoscopic treatment of superficially spreading colorectal neoplasms larger than 20 mm. Gastrointest Endosc 2001;54:62–66.PMID: 11427843.ArticlePubMed
  • 5. Yang DH, Jeong GH, Song Y, et al. The feasibility of performing colorectal endoscopic submucosal dissection without previous experience in performing gastric endoscopic submucosal dissection. Dig Dis Sci 2015;60:3431–3441.PMID: 26088371.ArticlePubMed
  • 6. Woodward TA, Heckman MG, Cleveland P, De Melo S, Raimondo M, Wallace M. Predictors of complete endoscopic mucosal resection of flat and depressed gastrointestinal neoplasia of the colon. Am J Gastroenterol 2012;107:650–654.PMID: 22552236.ArticlePubMedPDF
  • 7. Saito Y, Fukuzawa M, Matsuda T, et al. Clinical outcome of endoscopic submucosal dissection versus endoscopic mucosal resection of large colorectal tumors as determined by curative resection. Surg Endosc 2010;24:343–352.PMID: 19517168.ArticlePubMed
  • 8. Lee EJ, Lee JB, Lee SH, Youk EG. Endoscopic treatment of large colorectal tumors: comparison of endoscopic mucosal resection, endoscopic mucosal resection-precutting, and endoscopic submucosal dissection. Surg Endosc 2012;26:2220–2230.PMID: 22278105.ArticlePubMed
  • 9. Tajika M, Niwa Y, Bhatia V, et al. Comparison of endoscopic submucosal dissection and endoscopic mucosal resection for large colorectal tumors. Eur J Gastroenterol Hepatol 2011;23:1042–1049.PMID: 21869682.ArticlePubMed
  • 10. Byeon JS, Yang DH, Kim KJ, et al. Endoscopic submucosal dissection with or without snaring for colorectal neoplasms. Gastrointest Endosc 2011;74:1075–1083.PMID: 21663905.ArticlePubMed
  • 11. Hong YM, Kim HW, Park SB, Choi CW, Kang DH. Endoscopic mucosal resection with circumferential incision for the treatment of large sessile polyps and laterally spreading tumors of the colorectum. Clin Endosc 2015;48:52–58.PMID: 25674527.ArticlePubMedPMC
  • 12. Sakamoto T, Matsuda T, Nakajima T, Saito Y. Efficacy of endoscopic mucosal resection with circumferential incision for patients with large colorectal tumors. Clin Gastroenterol Hepatol 2012;10:22–26.PMID: 22016034.ArticlePubMed
  • 13. Kim HG, Sethi S, Banerjee S, Friedland S. Outcomes of endoscopic treatment of second recurrences of large nonpedunculated colorectal adenomas. Surg Endosc 2016;30:2457–2464.PMID: 26423413.ArticlePubMedPDF
  • 14. Sakamoto T, Saito Y, Matsuda T, Fukunaga S, Nakajima T, Fujii T. Treatment strategy for recurrent or residual colorectal tumors after endoscopic resection. Surg Endosc 2011;25:255–260.PMID: 20559661.ArticlePubMed
  • 15. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251–255.PMID: 10896917.ArticlePubMedPMC
  • 16. Seo GJ, Sohn DK, Han KS, et al. Recurrence after endoscopic piecemeal mucosal resection for large sessile colorectal polyps. World J Gastroenterol 2010;16:2806–2811.PMID: 20533602.ArticlePubMedPMC
  • 17. Hotta K, Fujii T, Saito Y, Matsuda T. Local recurrence after endoscopic resection of colorectal tumors. Int J Colorectal Dis 2009;24:225–230.PMID: 18972121.ArticlePubMed
  • 18. Belderbos TD, Leenders M, Moons LM, Siersema PD. Local recurrence after endoscopic mucosal resection of nonpedunculated colorectal lesions: systematic review and meta-analysis. Endoscopy 2014;46:388–402.PMID: 24671869.ArticlePubMedPDF
  • 19. Sakamoto T, Matsuda T, Otake Y, Nakajima T, Saito Y. Predictive factors of local recurrence after endoscopic piecemeal mucosal resection. J Gastroenterol 2012;47:635–640.PMID: 22223177.ArticlePubMed
  • 20. Regula J, Wronska E, Polkowski M, et al. Argon plasma coagulation after piecemeal polypectomy of sessile colorectal adenomas: long-term follow-up study. Endoscopy 2003;35:212–218.PMID: 12584639.ArticlePubMedPDF
  • 21. Tsiamoulos ZP, Bourikas LA, Saunders BP. Endoscopic mucosal ablation: a new argon plasma coagulation/injection technique to assist complete resection of recurrent, fibrotic colon polyps (with video). Gastrointest Endosc 2012;75:400–404.PMID: 22154411.ArticlePubMed
  • 22. Holmes I, Kim HG, Yang DH, Friedland S. Avulsion is superior to argon plasma coagulation for treatment of visible residual neoplasia during EMR of colorectal polyps (with videos). Gastrointest Endosc 2016;84:822–829.PMID: 27080417.ArticlePubMed
  • 23. Kim HG, Thosani N, Banerjee S, Chen A, Friedland S. Underwater endoscopic mucosal resection for recurrences after previous piecemeal resection of colorectal polyps (with video). Gastrointest Endosc 2014;80:1094–1102.PMID: 25012560.ArticlePubMed
  • 24. Kim EK, Han DS, Ro Y, Eun CS, Yoo KS, Oh YH. The submucosal fibrosis: what does it mean for colorectal endoscopic submucosal dissection? Intest Res 2016;14:358–364.PMID: 27799887.ArticlePubMedPMC
Fig. 1

Flow diagram showing recurrence and subsequent endoscopic treatment. aEarly recurrence (red box) rates at the first surveillance were 5.8% (18/312) and 6.4% (3/47) after conventional endoscopic piecemeal mucosal resection (CEPMR) and precut EPMR (PEPMR), respectively; bAmong lesions without recurrence at the first surveillance colonoscopy, the rates of late recurrence (blue box) were 3.9% (6/152) and 0% after CEPMR and PEPMR, respectively. In summary, the overall recurrence rates were 7.7% (24/312) and 6.4% (3/47) after CEPMR and PEPMR, respectively.

ir-15-502-g001.jpg
Fig. 2

Conventional endoscopic piecemeal resection (EPMR) (A-E) and precut EPMR (F-J).

ir-15-502-g002.jpg
Table 1

Baseline Characteristics of Patients, Polyps, and EPMR Procedures

ir-15-502-i001.jpg
CEPMR (n=312) PEPMR (n=47) P-value
Age (yr) 63.0±9.8 62.3±9.9 0.629
Male sex 196 (62.8) 29 (61.7) 0.883
Experienced endoscopists 296 (94.9) 45 (95.7) >0.999
Location of lesions <0.001
 Cecum-ascending colon 175 (55.8) 11 (23.4)
 Transverse colon 52 (16.7) 10 (21.3)
 Descending colon-sigmoid colon 53 (17.0) 12 (25.5)
 Rectum 33 (10.6) 14 (29.8)
Morphology of lesions 0.642
 LST-G 127 (40.7) 21 (44.7)
 LST-NG 135 (43.3) 17 (36.2)
 Sessile/protruded 50 (16.0) 9 (19.1)
Prior biopsy 0.075
 No 75 (24.0) 6 (12.8)
 Yes 231 (74.0) 38 (80.9)
 Unknown 5 (1.6) 3 (6.4)
Lesion size (mm) 23.7±12.0 28.5±15.4 0.009
Non-lifting sign 50 (16.0) 10 (21.7) 0.333
Supplementary procedures after EPMR 0.310
 None 94 (30.1) 21 (44.7)
 Avulsion by hot biopsy forceps 26 (8.3) 4 (8.5)
 APC 153 (49.0) 19 (40.4)
 Avulsion+APC 3 (1.0) 0
 Snare tip coagulation 36 (11.5) 3 (6.4)

Values are presented as mean±SD or number (%)

EPMR, endoscopic piecemeal mucosal resection; CEPMR, conventional EPMR; PEPMR, precut EPMR; LST-G, laterally spreading tumor-granular type; LST-NG, LST-nongranular type; APC, argon plasma coagulation.

Table 2

Clinical Outcomes after EPMR

ir-15-502-i002.jpg
CEPMR (n=312) PEPMR (n=47) P-value
No. of resected pieces 3.4±2.3 3.2±1.7 0.903
Histology 0.072
 Adenoma/low grade dysplasia 173 (55.4) 23 (48.9)
 Adenoma/high grade dysplasia 63 (20.2) 14 (29.8)
 Sessile serrated adenoma/polyp 28 (9.0) 0
 Mucosal cancer 33 (10.6) 7 (14.9)
 Superficial submucosal cancer 6 (1.9) 3 (6.4)
 Deep submucosal cancera 1 (0.3) 0
 Others 8 (2.6) 0
Histological complete resection 125 (40.1) 15 (31.9) 0.003
Complication
 Perforation 3 (1.0) 1 (2.1) 0.431
 Intraprocedural bleeding 39 (12.5) 15 (31.9) 0.001
 Delayed bleeding
  Early delayed bleeding (≤48 hr) 9 (2.9) 3 (6.4) 0.198
  Late delayed bleeding (>48 hr) 3 (1.0) 1 (2.1) 0.431
Follow-up duration (mo) 20.5 (12.3–38.2) 18.2 (12.1–43.0) 0.696
No. of surveillance endoscopies 2.0±1.2 2.1±1.1 0.258
Overall recurrence 24 (7.7) 3 (6.4) 0.751

Values are presented as mean±SD, number (%), or median (interquartile range).

aThe patient refused additional surgery because of existing comorbidities of liver cirrhosis and lymphoma. She was followed up for 12 months without recurrence, but died of septic shock as a complication of lymphoma treatment after 3 years.

EPMR, endoscopic piecemeal mucosal resection; CEPMR, conventional EPMR; PEPMR, precut EPMR.

Table 3

Recurrence Rates According to Lesion Size

ir-15-502-i003.jpg
Recurrence rate CEPMR (n=312) PEPMR (n=47) Total (n=359) P-value
Overall recurrence 7.7 (24/312) 6.4 (3/47) 7.5 (27/359) >0.999
Recurrence in polyps ≥20 mm 10.6 (21/199) 7.9 (3/38) 10.1 (24/237) 0.775
Recurrence according to tumor size (mm)
 10–19 2.7 (3/113) 0 (0/9) 2.5 (3/122) >0.999
 20–29 7.4 (8/108) 12.5 (2/16) 8.1 (10/124) 0.626
 30–39 12.1 (7/58) 0 (0/13) 9.9 (7/71) 0.601
 ≥40 18.2 (6/33) 11.1 (1/9) 16.7 (7/42) >0.999
P-value 0.001 0.727 0.002

Values are presented as percent (number/total number).

CEPMR, conventional endoscopic piecemeal mucosal resection; PEPMR, precut EPMR.

Table 4

Univariate and Multivariate Analyses of Risk Factors for Local Recurrence

ir-15-502-i004.jpg
Univariate analysis Multivariate analysis
OR (95% CI) P-value OR (95% CI) P-value
Size of lesion (mm) 0.016 0.015
 <20 1 (reference) 1 (reference)
 20–39 3.79 (1.09–13.21) 3.79 (1.09–13.21) 0.037
 ≥40 7.93 (1.95–32.30) 7.93 (1.95–32.30) <0.001
Morphology of lesion 0.005
 Sessile/protruded 1 (reference)
 LST-NG 1.58 (0.36–6.81)
 LST-G 4.33 (1.57–11.93)
No. of pieces 0.019
 <4 1 (reference)
 ≥4 2.58 (1.17–5.69)
Perforation 0.032
 No 1 (reference)
 Yes 4.47 (1.14–17.67)

LST-NG, laterally spreading tumor-nongranular type; LST-G, LST-granular type.

Table 5

Endoscopic Treatment Methods for the First Recurrent Lesionsa after EPMR

ir-15-502-i005.jpg
Treatment modalities No. of cases (%)
Single modality 8 (29.6)
 Cold forceps polypectomy 5 (18.5)
 EMR 3 (11.1)
Combination modality 19 (70.4)
 Cold forceps polypectomy+APC 6 (22.2)
 Hot biopsy+APC 2 (7.4)
 EMR+APC 7 (25.9)
 EMR+hot biopsy 3 (11.1)
 EMR+hot biopsy+APC 1 (3.7)

aThe first recurrent lesions included both initial recurrences at the first surveillance endoscopy (n=21) and late recurrences at the second and third surveillance endoscopies without recurrence at the first surveillance endoscopy (n=6).

EPMR, endoscopic piecemeal mucosal resection; EMR, endoscopic mucosal resection; APC, argon plasma coagulation.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Cold Versus Hot Endoscopic Mucosal Resection for Sessile Serrated Colorectal Polyps ≥10 mm
      Talia F. Malik, Babu P. Mohan, Smit Deliwala, Lena L. Kassab, Saurabh Chandan, Neil R. Sharma, Douglas G. Adler
      Journal of Clinical Gastroenterology.2024; 58(9): 889.     CrossRef
    • Cold EMR vs. Hot EMR for the removal of sessile serrated polyps larger than 10 mm: a systematic review and meta-analysis
      Cong Ding, Jian-feng Yang, Xia Wang, Yi-feng Zhou, Hayat Khizar, Zheng Jin, Xiao-feng Zhang
      BMC Surgery.2024;[Epub]     CrossRef
    • Does precutting prior to endoscopic piecemeal resection of large colorectal neoplasias reduce local recurrence? A KASID multicenter study
      Hong Jin Yoon, Dae Kyung Sohn, Yunho Jung, Hyun Seok Lee, Hoon Sup Koo, Kyeong Ok Kim, Jeong Eun Shin, Hyun Gun Kim, Il Kwun Chung, Young Hwangbo
      Surgical Endoscopy.2022; 36(5): 3433.     CrossRef
    • Adenoma Recurrence after Endoscopic Piecemeal Mucosal Resection of Colorectal Flat Lesions: Applicability of the Sydney EMR Recurrence Tool in a Non-Tertiary Centre
      Maria Azevedo Silva, Carina Leal, André Ruge, Alexandra Fernandes, Liliana Eliseu, Helena Vasconcelos
      GE - Portuguese Journal of Gastroenterology.2022; 29(4): 247.     CrossRef
    • Management of the malignant colorectal polyp
      Matthew Symer, James Connolly, Heather Yeo
      Current Problems in Surgery.2022; 59(5): 101124.     CrossRef
    • Risk factors for local recurrence of large gastrointestinal lesions after endoscopic mucosal resection
      Yasar Colak, Badar Hasan, Walid Hassaballa, Mamoon Ur Rashid, Victor Strassmann, Giovanna DaSilva, Steven D. Wexner, Tolga Erim
      Techniques in Coloproctology.2022; 26(7): 545.     CrossRef
    • Cost of Endoscopic Submucosal Dissection Versus Endoscopic Piecemeal Mucosal Resection in the Colorectum
      Nam Seok Ham, Jeongseok Kim, Eun Hye Oh, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
      Digestive Diseases and Sciences.2020; 65(4): 969.     CrossRef
    • Clinical outcomes of submucosal colorectal cancer diagnosed after endoscopic resection: a focus on the need for surgery
      Yun Sik Choi, Wan Soo Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
      Intestinal Research.2020; 18(1): 96.     CrossRef
    • Efficacy and Safety of Endoscopic Resection of Sessile Serrated Polyps 10 mm or Larger: A Systematic Review and Meta-Analysis
      Viveksandeep Thoguluva Chandrasekar, Muhammad Aziz, Harsh K. Patel, Naaz Sidhu, Abhiram Duvvuri, ChandraShekhar Dasari, Kevin F. Kennedy, Ashwini Ashwath, Marco Spadaccini, Madhav Desai, Ramprasad Jegadeesan, Anjana Sathyamurthy, Prashanth Vennalaganti, D
      Clinical Gastroenterology and Hepatology.2020; 18(11): 2448.     CrossRef
    • Cold snare piecemeal EMR of large sessile colonic polyps ≥20 mm (with video)
      Dileep Mangira, Karla Cameron, Koen Simons, Simon Zanati, Richard LaNauze, Spiro Raftopoulos, Gregor Brown, Alan Moss
      Gastrointestinal Endoscopy.2020; 91(6): 1343.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Local recurrence and subsequent endoscopic treatment after endoscopic piecemeal mucosal resection with or without precutting in the colorectum
      Intest Res. 2017;15(4):502-510.   Published online October 23, 2017
      DOI: https://doi.org/10.5217/ir.2017.15.4.502
      Close
    • XML DownloadXML Download
    Figure
    • 0
    • 1
    Local recurrence and subsequent endoscopic treatment after endoscopic piecemeal mucosal resection with or without precutting in the colorectum
    Image Image
    Fig. 1 Flow diagram showing recurrence and subsequent endoscopic treatment. aEarly recurrence (red box) rates at the first surveillance were 5.8% (18/312) and 6.4% (3/47) after conventional endoscopic piecemeal mucosal resection (CEPMR) and precut EPMR (PEPMR), respectively; bAmong lesions without recurrence at the first surveillance colonoscopy, the rates of late recurrence (blue box) were 3.9% (6/152) and 0% after CEPMR and PEPMR, respectively. In summary, the overall recurrence rates were 7.7% (24/312) and 6.4% (3/47) after CEPMR and PEPMR, respectively.
    Fig. 2 Conventional endoscopic piecemeal resection (EPMR) (A-E) and precut EPMR (F-J).

    Fig. 1

    Fig. 2

    Local recurrence and subsequent endoscopic treatment after endoscopic piecemeal mucosal resection with or without precutting in the colorectum

    Baseline Characteristics of Patients, Polyps, and EPMR Procedures

    CEPMR (n=312)PEPMR (n=47)P-value
    Age (yr)63.0±9.862.3±9.90.629
    Male sex196 (62.8)29 (61.7)0.883
    Experienced endoscopists296 (94.9)45 (95.7)>0.999
    Location of lesions<0.001
     Cecum-ascending colon175 (55.8)11 (23.4)
     Transverse colon52 (16.7)10 (21.3)
     Descending colon-sigmoid colon53 (17.0)12 (25.5)
     Rectum33 (10.6)14 (29.8)
    Morphology of lesions0.642
     LST-G127 (40.7)21 (44.7)
     LST-NG135 (43.3)17 (36.2)
     Sessile/protruded50 (16.0)9 (19.1)
    Prior biopsy0.075
     No75 (24.0)6 (12.8)
     Yes231 (74.0)38 (80.9)
     Unknown5 (1.6)3 (6.4)
    Lesion size (mm)23.7±12.028.5±15.40.009
    Non-lifting sign50 (16.0)10 (21.7)0.333
    Supplementary procedures after EPMR0.310
     None94 (30.1)21 (44.7)
     Avulsion by hot biopsy forceps26 (8.3)4 (8.5)
     APC153 (49.0)19 (40.4)
     Avulsion+APC3 (1.0)0
     Snare tip coagulation36 (11.5)3 (6.4)

    Values are presented as mean±SD or number (%)

    EPMR, endoscopic piecemeal mucosal resection; CEPMR, conventional EPMR; PEPMR, precut EPMR; LST-G, laterally spreading tumor-granular type; LST-NG, LST-nongranular type; APC, argon plasma coagulation.

    Clinical Outcomes after EPMR

    CEPMR (n=312)PEPMR (n=47)P-value
    No. of resected pieces3.4±2.33.2±1.70.903
    Histology0.072
     Adenoma/low grade dysplasia173 (55.4)23 (48.9)
     Adenoma/high grade dysplasia63 (20.2)14 (29.8)
     Sessile serrated adenoma/polyp28 (9.0)0
     Mucosal cancer33 (10.6)7 (14.9)
     Superficial submucosal cancer6 (1.9)3 (6.4)
     Deep submucosal cancera1 (0.3)0
     Others8 (2.6)0
    Histological complete resection125 (40.1)15 (31.9)0.003
    Complication
     Perforation3 (1.0)1 (2.1)0.431
     Intraprocedural bleeding39 (12.5)15 (31.9)0.001
     Delayed bleeding
      Early delayed bleeding (≤48 hr)9 (2.9)3 (6.4)0.198
      Late delayed bleeding (>48 hr)3 (1.0)1 (2.1)0.431
    Follow-up duration (mo)20.5 (12.3–38.2)18.2 (12.1–43.0)0.696
    No. of surveillance endoscopies2.0±1.22.1±1.10.258
    Overall recurrence24 (7.7)3 (6.4)0.751

    Values are presented as mean±SD, number (%), or median (interquartile range).

    aThe patient refused additional surgery because of existing comorbidities of liver cirrhosis and lymphoma. She was followed up for 12 months without recurrence, but died of septic shock as a complication of lymphoma treatment after 3 years.

    EPMR, endoscopic piecemeal mucosal resection; CEPMR, conventional EPMR; PEPMR, precut EPMR.

    Recurrence Rates According to Lesion Size

    Recurrence rateCEPMR (n=312)PEPMR (n=47)Total (n=359)P-value
    Overall recurrence7.7 (24/312)6.4 (3/47)7.5 (27/359)>0.999
    Recurrence in polyps ≥20 mm10.6 (21/199)7.9 (3/38)10.1 (24/237)0.775
    Recurrence according to tumor size (mm)
     10–192.7 (3/113)0 (0/9)2.5 (3/122)>0.999
     20–297.4 (8/108)12.5 (2/16)8.1 (10/124)0.626
     30–3912.1 (7/58)0 (0/13)9.9 (7/71)0.601
     ≥4018.2 (6/33)11.1 (1/9)16.7 (7/42)>0.999
    P-value0.0010.7270.002

    Values are presented as percent (number/total number).

    CEPMR, conventional endoscopic piecemeal mucosal resection; PEPMR, precut EPMR.

    Univariate and Multivariate Analyses of Risk Factors for Local Recurrence

    Univariate analysisMultivariate analysis
    OR (95% CI)P-valueOR (95% CI)P-value
    Size of lesion (mm)0.0160.015
     <201 (reference)1 (reference)
     20–393.79 (1.09–13.21)3.79 (1.09–13.21)0.037
     ≥407.93 (1.95–32.30)7.93 (1.95–32.30)<0.001
    Morphology of lesion0.005
     Sessile/protruded1 (reference)
     LST-NG1.58 (0.36–6.81)
     LST-G4.33 (1.57–11.93)
    No. of pieces0.019
     <41 (reference)
     ≥42.58 (1.17–5.69)
    Perforation0.032
     No1 (reference)
     Yes4.47 (1.14–17.67)

    LST-NG, laterally spreading tumor-nongranular type; LST-G, LST-granular type.

    Endoscopic Treatment Methods for the First Recurrent Lesionsa after EPMR

    Treatment modalitiesNo. of cases (%)
    Single modality8 (29.6)
     Cold forceps polypectomy5 (18.5)
     EMR3 (11.1)
    Combination modality19 (70.4)
     Cold forceps polypectomy+APC6 (22.2)
     Hot biopsy+APC2 (7.4)
     EMR+APC7 (25.9)
     EMR+hot biopsy3 (11.1)
     EMR+hot biopsy+APC1 (3.7)

    aThe first recurrent lesions included both initial recurrences at the first surveillance endoscopy (n=21) and late recurrences at the second and third surveillance endoscopies without recurrence at the first surveillance endoscopy (n=6).

    EPMR, endoscopic piecemeal mucosal resection; EMR, endoscopic mucosal resection; APC, argon plasma coagulation.
    Table 1 Baseline Characteristics of Patients, Polyps, and EPMR Procedures

    Values are presented as mean±SD or number (%)

    EPMR, endoscopic piecemeal mucosal resection; CEPMR, conventional EPMR; PEPMR, precut EPMR; LST-G, laterally spreading tumor-granular type; LST-NG, LST-nongranular type; APC, argon plasma coagulation.

    Table 2 Clinical Outcomes after EPMR

    Values are presented as mean±SD, number (%), or median (interquartile range).

    aThe patient refused additional surgery because of existing comorbidities of liver cirrhosis and lymphoma. She was followed up for 12 months without recurrence, but died of septic shock as a complication of lymphoma treatment after 3 years.

    EPMR, endoscopic piecemeal mucosal resection; CEPMR, conventional EPMR; PEPMR, precut EPMR.

    Table 3 Recurrence Rates According to Lesion Size

    Values are presented as percent (number/total number).

    CEPMR, conventional endoscopic piecemeal mucosal resection; PEPMR, precut EPMR.

    Table 4 Univariate and Multivariate Analyses of Risk Factors for Local Recurrence

    LST-NG, laterally spreading tumor-nongranular type; LST-G, LST-granular type.

    Table 5 Endoscopic Treatment Methods for the First Recurrent Lesionsa after EPMR

    aThe first recurrent lesions included both initial recurrences at the first surveillance endoscopy (n=21) and late recurrences at the second and third surveillance endoscopies without recurrence at the first surveillance endoscopy (n=6).

    EPMR, endoscopic piecemeal mucosal resection; EMR, endoscopic mucosal resection; APC, argon plasma coagulation.

    Table 1

    Table 2

    Table 3

    Table 4

    Table 5

    Intest Res : Intestinal Research
    © Korean Association for the Study of Intestinal Diseases.
    Close layer
    TOP